Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 4, Issue 6, Pages 895-903
Publisher
Future Medicine Ltd
Online
2010-12-07
DOI
10.2217/bmm.10.104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KRAS mutation status in primary nonsmall cell lung cancer and matched metastases
- (2010) Alexis B. Cortot et al. CANCER
- International Efforts to Develop Biospecimen Best Practices
- (2010) J. B. Vaught et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Examining the public refusal to consent to DNA biobanking: empirical data from a Swedish population-based study
- (2010) P. A. Melas et al. JOURNAL OF MEDICAL ETHICS
- The role of the pathologist in tissue banking: European Consensus Expert Group Report
- (2010) Generoso Bevilacqua et al. VIRCHOWS ARCHIV
- Biobanks and the importance of detailed phenotyping: a case study--the European Glaucoma Society GlaucoGENE project
- (2009) P Founti et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Human Biospecimen Research: Experimental Protocol and Quality Control Tools
- (2009) F. Betsou et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- 2009 Biospecimen Research Network Symposium: Advancing Cancer Research through Biospecimen Science
- (2009) H. M. Moore et al. CANCER RESEARCH
- Sources of Bias in Specimens for Research About Molecular Markers for Cancer
- (2009) David F. Ransohoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Ethics and biobanks
- (2008) M G Hansson BRITISH JOURNAL OF CANCER
- Cancers Exhibit a Mutator Phenotype: Clinical Implications
- (2008) L. A. Loeb et al. CANCER RESEARCH
- Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology
- (2008) P. R. Burton et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non–Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting
- (2008) David A. Eberhard et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteomic Contributions to Personalized Cancer Care
- (2008) John M. Koomen et al. MOLECULAR & CELLULAR PROTEOMICS
- The Stockholm Declaration
- (2008) Ulrik Ringborg Molecular Oncology
- Enabling personalized cancer medicine through analysis of gene-expression patterns
- (2008) Laura J. van 't Veer et al. NATURE
- The cancer biomarker problem
- (2008) Charles L. Sawyers NATURE
- Sample, data use and protection in biobanking in Europe: legal issues
- (2008) Eleni Zika et al. PHARMACOGENOMICS
- Biobanking: old activity or young discipline?
- (2008) Manuel M. Morente et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
- (2008) Vathany Kulasingam et al. Nature clinical practice. Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation